Future Market Insights predicts that the proteome balms market will be reshaped by biotechnology advances that will replace generic emollients with targeted protein-based actives, creating a category where cellular-level skin repair mechanisms will address barrier dysfunction at its molecular source. Over the forecast period, the industry will transition from commodity lip care toward precision dermatology formulations, where proteomic peptides and bioengineered proteins will become standard ingredients across professional clinical and consumer retail channels.